Global Allogeneic Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 101

Published Date: 02 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Allogeneic Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Allogeneic Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Allogeneic Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Allogeneic Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Allogeneic Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Allogeneic Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Allogeneic Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Allogeneic Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive and Chiesi Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Allogeneic Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Adult Stem Cell Therapy
    Human Embryonic Stem Cell Therapy
    Induced Pluripotent Stem Cell Therapy
    Others

Market segment by Application
    Musculoskeletal Disorder
    Wounds & Injuries
    Cardiovascular Diseases
    Others

Market segment by players, this report covers
    Escape Therapeutics, Inc.
    Lonza Group Ltd.
    Osiris Therapeutics (Smith & Nephew)
    NuVasive
    Chiesi Pharmaceuticals
    JCR Pharmaceutical
    Pharmicell
    Anterogen
    MolMed S.p.A.
    Takeda (TiGenix)

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Allogeneic Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Allogeneic Stem Cell Therapy, with revenue, gross margin and global market share of Allogeneic Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Allogeneic Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Allogeneic Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Allogeneic Stem Cell Therapy.
Chapter 13, to describe Allogeneic Stem Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Allogeneic Stem Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Allogeneic Stem Cell Therapy by Type
        1.3.1 Overview: Global Allogeneic Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Allogeneic Stem Cell Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Adult Stem Cell Therapy
        1.3.4 Human Embryonic Stem Cell Therapy
        1.3.5 Induced Pluripotent Stem Cell Therapy
        1.3.6 Others
    1.4 Global Allogeneic Stem Cell Therapy Market by Application
        1.4.1 Overview: Global Allogeneic Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Musculoskeletal Disorder
        1.4.3 Wounds & Injuries
        1.4.4 Cardiovascular Diseases
        1.4.5 Others
    1.5 Global Allogeneic Stem Cell Therapy Market Size & Forecast
    1.6 Global Allogeneic Stem Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Allogeneic Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Allogeneic Stem Cell Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Allogeneic Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Allogeneic Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Allogeneic Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Allogeneic Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Allogeneic Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Escape Therapeutics, Inc.
        2.1.1 Escape Therapeutics, Inc. Details
        2.1.2 Escape Therapeutics, Inc. Major Business
        2.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product and Solutions
        2.1.4 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Escape Therapeutics, Inc. Recent Developments and Future Plans
    2.2 Lonza Group Ltd.
        2.2.1 Lonza Group Ltd. Details
        2.2.2 Lonza Group Ltd. Major Business
        2.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Product and Solutions
        2.2.4 Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Lonza Group Ltd. Recent Developments and Future Plans
    2.3 Osiris Therapeutics (Smith & Nephew)
        2.3.1 Osiris Therapeutics (Smith & Nephew) Details
        2.3.2 Osiris Therapeutics (Smith & Nephew) Major Business
        2.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product and Solutions
        2.3.4 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Osiris Therapeutics (Smith & Nephew) Recent Developments and Future Plans
    2.4 NuVasive
        2.4.1 NuVasive Details
        2.4.2 NuVasive Major Business
        2.4.3 NuVasive Allogeneic Stem Cell Therapy Product and Solutions
        2.4.4 NuVasive Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 NuVasive Recent Developments and Future Plans
    2.5 Chiesi Pharmaceuticals
        2.5.1 Chiesi Pharmaceuticals Details
        2.5.2 Chiesi Pharmaceuticals Major Business
        2.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product and Solutions
        2.5.4 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Chiesi Pharmaceuticals Recent Developments and Future Plans
    2.6 JCR Pharmaceutical
        2.6.1 JCR Pharmaceutical Details
        2.6.2 JCR Pharmaceutical Major Business
        2.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Product and Solutions
        2.6.4 JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 JCR Pharmaceutical Recent Developments and Future Plans
    2.7 Pharmicell
        2.7.1 Pharmicell Details
        2.7.2 Pharmicell Major Business
        2.7.3 Pharmicell Allogeneic Stem Cell Therapy Product and Solutions
        2.7.4 Pharmicell Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Pharmicell Recent Developments and Future Plans
    2.8 Anterogen
        2.8.1 Anterogen Details
        2.8.2 Anterogen Major Business
        2.8.3 Anterogen Allogeneic Stem Cell Therapy Product and Solutions
        2.8.4 Anterogen Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Anterogen Recent Developments and Future Plans
    2.9 MolMed S.p.A.
        2.9.1 MolMed S.p.A. Details
        2.9.2 MolMed S.p.A. Major Business
        2.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Product and Solutions
        2.9.4 MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 MolMed S.p.A. Recent Developments and Future Plans
    2.10 Takeda (TiGenix)
        2.10.1 Takeda (TiGenix) Details
        2.10.2 Takeda (TiGenix) Major Business
        2.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Product and Solutions
        2.10.4 Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Takeda (TiGenix) Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Allogeneic Stem Cell Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Allogeneic Stem Cell Therapy by Company Revenue
        3.2.2 Top 3 Allogeneic Stem Cell Therapy Players Market Share in 2022
        3.2.3 Top 6 Allogeneic Stem Cell Therapy Players Market Share in 2022
    3.3 Allogeneic Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Allogeneic Stem Cell Therapy Market: Region Footprint
        3.3.2 Allogeneic Stem Cell Therapy Market: Company Product Type Footprint
        3.3.3 Allogeneic Stem Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Allogeneic Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Allogeneic Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Allogeneic Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Allogeneic Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2029)
    6.2 North America Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2029)
    6.3 North America Allogeneic Stem Cell Therapy Market Size by Country
        6.3.1 North America Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Allogeneic Stem Cell Therapy Market Size by Country
        7.3.1 Europe Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2029)
    9.2 South America Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2029)
    9.3 South America Allogeneic Stem Cell Therapy Market Size by Country
        9.3.1 South America Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Allogeneic Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Allogeneic Stem Cell Therapy Market Drivers
    11.2 Allogeneic Stem Cell Therapy Market Restraints
    11.3 Allogeneic Stem Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Allogeneic Stem Cell Therapy Industry Chain
    12.2 Allogeneic Stem Cell Therapy Upstream Analysis
    12.3 Allogeneic Stem Cell Therapy Midstream Analysis
    12.4 Allogeneic Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Allogeneic Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Allogeneic Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Allogeneic Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Allogeneic Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Escape Therapeutics, Inc. Company Information, Head Office, and Major Competitors
    Table 6. Escape Therapeutics, Inc. Major Business
    Table 7. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product and Solutions
    Table 8. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Escape Therapeutics, Inc. Recent Developments and Future Plans
    Table 10. Lonza Group Ltd. Company Information, Head Office, and Major Competitors
    Table 11. Lonza Group Ltd. Major Business
    Table 12. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product and Solutions
    Table 13. Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Lonza Group Ltd. Recent Developments and Future Plans
    Table 15. Osiris Therapeutics (Smith & Nephew) Company Information, Head Office, and Major Competitors
    Table 16. Osiris Therapeutics (Smith & Nephew) Major Business
    Table 17. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product and Solutions
    Table 18. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Osiris Therapeutics (Smith & Nephew) Recent Developments and Future Plans
    Table 20. NuVasive Company Information, Head Office, and Major Competitors
    Table 21. NuVasive Major Business
    Table 22. NuVasive Allogeneic Stem Cell Therapy Product and Solutions
    Table 23. NuVasive Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. NuVasive Recent Developments and Future Plans
    Table 25. Chiesi Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 26. Chiesi Pharmaceuticals Major Business
    Table 27. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product and Solutions
    Table 28. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Chiesi Pharmaceuticals Recent Developments and Future Plans
    Table 30. JCR Pharmaceutical Company Information, Head Office, and Major Competitors
    Table 31. JCR Pharmaceutical Major Business
    Table 32. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product and Solutions
    Table 33. JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. JCR Pharmaceutical Recent Developments and Future Plans
    Table 35. Pharmicell Company Information, Head Office, and Major Competitors
    Table 36. Pharmicell Major Business
    Table 37. Pharmicell Allogeneic Stem Cell Therapy Product and Solutions
    Table 38. Pharmicell Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Pharmicell Recent Developments and Future Plans
    Table 40. Anterogen Company Information, Head Office, and Major Competitors
    Table 41. Anterogen Major Business
    Table 42. Anterogen Allogeneic Stem Cell Therapy Product and Solutions
    Table 43. Anterogen Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Anterogen Recent Developments and Future Plans
    Table 45. MolMed S.p.A. Company Information, Head Office, and Major Competitors
    Table 46. MolMed S.p.A. Major Business
    Table 47. MolMed S.p.A. Allogeneic Stem Cell Therapy Product and Solutions
    Table 48. MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. MolMed S.p.A. Recent Developments and Future Plans
    Table 50. Takeda (TiGenix) Company Information, Head Office, and Major Competitors
    Table 51. Takeda (TiGenix) Major Business
    Table 52. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product and Solutions
    Table 53. Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Takeda (TiGenix) Recent Developments and Future Plans
    Table 55. Global Allogeneic Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
    Table 56. Global Allogeneic Stem Cell Therapy Revenue Share by Players (2018-2023)
    Table 57. Breakdown of Allogeneic Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Allogeneic Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key Allogeneic Stem Cell Therapy Players
    Table 60. Allogeneic Stem Cell Therapy Market: Company Product Type Footprint
    Table 61. Allogeneic Stem Cell Therapy Market: Company Product Application Footprint
    Table 62. Allogeneic Stem Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 63. Allogeneic Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Allogeneic Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global Allogeneic Stem Cell Therapy Consumption Value Share by Type (2018-2023)
    Table 66. Global Allogeneic Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
    Table 67. Global Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2023)
    Table 68. Global Allogeneic Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
    Table 69. North America Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America Allogeneic Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. North America Allogeneic Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. North America Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America Allogeneic Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe Allogeneic Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 78. Europe Allogeneic Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 79. Europe Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Allogeneic Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 84. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 85. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America Allogeneic Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 90. South America Allogeneic Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 91. South America Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America Allogeneic Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 96. Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa Allogeneic Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. Allogeneic Stem Cell Therapy Raw Material
    Table 100. Key Suppliers of Allogeneic Stem Cell Therapy Raw Materials
List of Figures
    Figure 1. Allogeneic Stem Cell Therapy Picture
    Figure 2. Global Allogeneic Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Allogeneic Stem Cell Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Adult Stem Cell Therapy
    Figure 5. Human Embryonic Stem Cell Therapy
    Figure 6. Induced Pluripotent Stem Cell Therapy
    Figure 7. Others
    Figure 8. Global Allogeneic Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Allogeneic Stem Cell Therapy Consumption Value Market Share by Application in 2022
    Figure 10. Musculoskeletal Disorder Picture
    Figure 11. Wounds & Injuries Picture
    Figure 12. Cardiovascular Diseases Picture
    Figure 13. Others Picture
    Figure 14. Global Allogeneic Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Allogeneic Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Allogeneic Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Allogeneic Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Allogeneic Stem Cell Therapy Consumption Value Market Share by Region in 2022
    Figure 19. North America Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Allogeneic Stem Cell Therapy Revenue Share by Players in 2022
    Figure 25. Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Allogeneic Stem Cell Therapy Market Share in 2022
    Figure 27. Global Top 6 Players Allogeneic Stem Cell Therapy Market Share in 2022
    Figure 28. Global Allogeneic Stem Cell Therapy Consumption Value Share by Type (2018-2023)
    Figure 29. Global Allogeneic Stem Cell Therapy Market Share Forecast by Type (2024-2029)
    Figure 30. Global Allogeneic Stem Cell Therapy Consumption Value Share by Application (2018-2023)
    Figure 31. Global Allogeneic Stem Cell Therapy Market Share Forecast by Application (2024-2029)
    Figure 32. North America Allogeneic Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Allogeneic Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Allogeneic Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Allogeneic Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Allogeneic Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Allogeneic Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Allogeneic Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Allogeneic Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Allogeneic Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Allogeneic Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Allogeneic Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Allogeneic Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Allogeneic Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Allogeneic Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 66. Allogeneic Stem Cell Therapy Market Drivers
    Figure 67. Allogeneic Stem Cell Therapy Market Restraints
    Figure 68. Allogeneic Stem Cell Therapy Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Allogeneic Stem Cell Therapy in 2022
    Figure 71. Manufacturing Process Analysis of Allogeneic Stem Cell Therapy
    Figure 72. Allogeneic Stem Cell Therapy Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)

Related Reports

Global Allogeneic Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

Global Allogeneic Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

date 22 Apr 2023

date Medical Care

The global Allogeneic Stem Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Allogeneic Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Allogeneic Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Allogeneic Stem Cell Therapy market size was valued at USD 779.2 million in 2023 and is forecast to a readjusted size of USD 1513.9 million by 2030 with a CAGR of 10.0% during review period.

Product Tags

Allogeneic Stem Cell Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>